Search

everythinglearnresearchcommunity

for

Search:↓

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Most patients improved with oral contraceptives, but some needed additional treatment.

Normal levels of DHT can reduce belly fat and increase muscle, but too much can lead to hair loss, prostate issues, and possibly heart disease.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Most doctors know the thrombosis risk with Cyproterone/Ethinylestradiol, but some lack details on less common risks and patient instructions; educational materials are underused but useful.

The method allows for 3D tracking of hair follicle stem cells and shows they can regenerate hair for up to 180 days.

A woman with a rare adrenal tumor and hormonal disorder had improved testosterone levels after surgery, but her menstrual irregularities continued.

Excess male hormones in postmenopausal women can cause health issues and increase the risk of heart disease and diabetes; treatment depends on the cause.

Menopause can cause skin issues, and seeing a dermatologist helps.

Finasteride affects frog testes by increasing testosterone, decreasing 5α-DHT, and impacting genes related to reproduction and other functions.

Men's hair loss is not linked to their sex hormone levels, except for lower DHEAS in those with hair loss.

Finasteride causes temporary cell death in BPH tissues.

Higher levels of MiR-92a-1-5p and miR-328-3p found in female hair loss patients.

Testosterone replacement can help menopausal women with various symptoms, but should be used carefully and is not yet officially licensed in the UK for women.

Sex hormones might influence bladder cancer development, and aromatase inhibitors could increase risk in postmenopausal women.

The conclusion is that lifestyle changes and weight loss are first-line treatments for infertility due to anovulation, with various medications and assisted reproductive technologies as additional options.

Decanoic acid may help treat PCOS by reducing androgen levels and improving glucose sensitivity.

Ovarian Hyperthecosis caused hypersexuality in an older woman and was successfully treated with surgery.

Hormone treatment before hypospadias surgery can increase penis size and reduce surgery complications.

Hormone therapy for breast cancer often leads to sexual issues like vaginal dryness and decreased libido.

The conclusion introduces a new way to classify skin cysts using their shape and genetic markers.

A new peptide, FOL-005, may help treat excessive hair growth by reducing a hair growth promoter, FGF7.

17β-estradiol may help hair growth by increasing cannabinoid receptor type 1.

Removing Lrig1-positive stem cells in mice causes temporary loss of sebaceous glands.

Electrical epilation damages hair follicles and surrounding skin, likely preventing hair regrowth.

Eating a lot of soy might lower the chance of early hair loss in men likely to get it.